81.41  7.57 (10.25%)		09-11 16:00
Open: 74.73 High: 87.5 Volume: 257,945		Pre. Close: 73.84 Low: 72.45 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	114.71	1-year :	168
Resists	First :	98.21	Second :	143.83
Pivot price	84.3
Supports	First :	24.4	Second :	20.3
MAs	MA(5) :	78.02	MA(20) :	78.81
	MA(100) :	38.59	MA(250) :	0
MACD	MACD :	9.3	Signal :	11.8
%K %D	K(14,3) :	20.4	D(3) :	24.9
RSI	RSI(14): 55.1
52-week	High :	143.83	Low :	14.94

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ MRNX ] has closed above bottom band by 41.0%. Bollinger Bands are 2.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	87.65 - 88.07	88.07 - 88.45
Low:	71.57 - 71.98	71.98 - 72.36
Close:	80.65 - 81.41	81.41 - 82.09

The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.

Fri, 11 Sep 2026
KATT ETF Price and Chart — CBOE:KATT - TradingView

Mon, 31 Aug 2026
Best-Performing Leveraged ETFs of August - TradingView

Mon, 24 Aug 2026
Best-Performing Leveraged ETF Areas of Last Week - The Globe and Mail

Wed, 04 Feb 2026
MRNX ETF Price and Chart — AMEX:MRNX - TradingView

Wed, 04 Feb 2026
Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc. - Yahoo Finance

Wed, 01 Oct 2025
TBXU ETF Price and Chart — AMEX:TBXU - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management - Leveraged
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.